Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Singing voice handicap and videostrobolaryngoscopy in healthy professional singers.

Castelblanco L, Habib M, Stein DJ, de Quadros A, Cohen SM, Noordzij JP.

J Voice. 2014 Sep;28(5):608-13. doi: 10.1016/j.jvoice.2014.03.003. Epub 2014 May 16.

PMID:
24836361
2.

Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier.

Paris D, Bachmeier C, Patel N, Quadros A, Volmar CH, Laporte V, Ganey J, Beaulieu-Abdelahad D, Ait-Ghezala G, Crawford F, Mullan MJ.

Mol Med. 2011 Mar-Apr;17(3-4):149-62. doi: 10.2119/molmed.2010.00180. Epub 2010 Dec 17.

3.

Anti-Tumoral Activity of a Short Decapeptide Fragment of the Alzheimer's Abeta Peptide.

Paris D, Patel N, Ganey NJ, Laporte V, Quadros A, Mullan MJ.

Int J Pept Res Ther. 2010;16(1):23-30.

4.

Serum beta-amyloid correlates with neuropsychological impairment.

Luis CA, Abdullah L, Paris D, Quadros A, Mullan M, Mouzon B, Ait-Ghezala G, Crawford F, Mullan M.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2009 Mar;16(2):203-18. doi: 10.1080/13825580802411766.

PMID:
18923961
5.

Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease.

Ait-ghezala G, Abdullah L, Volmar CH, Paris D, Luis CA, Quadros A, Mouzon B, Mullan MA, Keegan AP, Parrish J, Crawford FC, Mathura VS, Mullan MJ.

Cytokine. 2008 Nov;44(2):283-7. doi: 10.1016/j.cyto.2008.08.013. Epub 2008 Oct 2.

PMID:
18835787
6.

Potent anti-angiogenic motifs within the Alzheimer beta-amyloid peptide.

Patel NS, Quadros A, Brem S, Wotoczek-Obadia M, Mathura VS, Laporte V, Mullan M, Paris D.

Amyloid. 2008 Mar;15(1):5-19. doi: 10.1080/13506120701814723.

PMID:
18266117
7.

The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.

Abdullah L, Paris D, Luis C, Quadros A, Parrish J, Valdes L, Keegan AP, Mathura V, Crawford F, Mullan M.

Neurosci Lett. 2007 Nov 27;428(2-3):53-8. Epub 2007 Oct 2.

PMID:
17964720
8.

[Percutaneous coronary intervention in diabetes mellitus: an updated analysis of medical practice].

Quadros A, Diemer F, Lima T, Abdalla R, Vizotto M, Gottschall CA, Schaan BD.

Arq Bras Endocrinol Metabol. 2007 Mar;51(2):327-33. Review. Portuguese.

9.

Inhibition of Abeta production by NF-kappaB inhibitors.

Paris D, Patel N, Quadros A, Linan M, Bakshi P, Ait-Ghezala G, Mullan M.

Neurosci Lett. 2007 Mar 19;415(1):11-6. Epub 2006 Dec 27.

PMID:
17223266
10.

[Diabetes and coronary stent implantation: experience from a reference center in interventional cardiology].

Schaan BD, Quadros A, Sarmento-Leite R, Gottschall CA.

Arq Bras Endocrinol Metabol. 2006 Feb;50(1):38-45. Epub 2006 Apr 17. Portuguese.

11.

Genomic regulation after CD40 stimulation in microglia: relevance to Alzheimer's disease.

Ait-Ghezala G, Mathura VS, Laporte V, Quadros A, Paris D, Patel N, Volmar CH, Kolippakkam D, Crawford F, Mullan M.

Brain Res Mol Brain Res. 2005 Oct 31;140(1-2):73-85. Epub 2005 Sep 22.

PMID:
16182406
12.

Model of Alzheimer's disease amyloid-beta peptide based on a RNA binding protein.

Mathura VS, Paris D, Ait-Ghezala G, Quadros A, Patel NS, Kolippakkam DN, Volmar CH, Mullan MJ.

Biochem Biophys Res Commun. 2005 Jul 1;332(2):585-92.

PMID:
15896718
13.

Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cells.

Paris D, Ait-Ghezala G, Mathura VS, Patel N, Quadros A, Laporte V, Mullan M.

Brain Res Mol Brain Res. 2005 May 20;136(1-2):212-30. Epub 2005 Apr 1.

PMID:
15893605
14.

Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors.

Paris D, Quadros A, Patel N, DelleDonne A, Humphrey J, Mullan M.

Eur J Pharmacol. 2005 May 2;514(1):1-15.

PMID:
15878319
15.

Inhibition of angiogenesis by Abeta peptides.

Paris D, Townsend K, Quadros A, Humphrey J, Sun J, Brem S, Wotoczek-Obadia M, DelleDonne A, Patel N, Obregon DF, Crescentini R, Abdullah L, Coppola D, Rojiani AM, Crawford F, Sebti SM, Mullan M.

Angiogenesis. 2004;7(1):75-85.

PMID:
15302999
16.

Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis.

Paris D, Patel N, DelleDonne A, Quadros A, Smeed R, Mullan M.

Neurosci Lett. 2004 Aug 5;366(1):80-5.

PMID:
15265595
17.

Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice.

Paris D, Quadros A, Humphrey J, Patel N, Crescentini R, Crawford F, Mullan M.

Brain Res. 2004 Feb 27;999(1):53-61.

PMID:
14746921
18.

Increased TNFalpha production and Cox-2 activity in organotypic brain slice cultures from APPsw transgenic mice.

Quadros A, Patel N, Crescentini R, Crawford F, Paris D, Mullan M.

Neurosci Lett. 2003 Dec 15;353(1):66-8.

PMID:
14642439
19.

Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation.

Paris D, Humphrey J, Quadros A, Patel N, Crescentini R, Crawford F, Mullan M.

Neurol Res. 2003 Sep;25(6):642-51.

PMID:
14503019
20.

[Worsening of autosomal dominant restless legs syndrome after use of mirtazapine: case report].

Teive HA, de Quadros A, Barros FC, Werneck LC.

Arq Neuropsiquiatr. 2002 Dec;60(4):1025-9. Epub 2003 Jan 15. Portuguese.

Supplemental Content

Loading ...
Support Center